Rose, A. A. N., Annis, M. G., Frederick, D. T., Biondini, M., Dong, Z., Kwong, L., . . . Siegel, P. M. (2016). MAPK Pathway Inhibitors Sensitize BRAF Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB. Clin Cancer Res.
शिकागो स्टाइल उद्धरणRose, April A. N., et al. "MAPK Pathway Inhibitors Sensitize BRAF Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB." Clin Cancer Res 2016.
एमएलए उद्धरणRose, April A. N., et al. "MAPK Pathway Inhibitors Sensitize BRAF Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB." Clin Cancer Res 2016.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.